Researcher

Title

• Clinical Assistant Professor
• Pediatric rheumatologist and immunologist at the Sainte-Justine university hospital center (2017)

• Certificate of Pediatrics, Royal College of Physicians and Surgeons of Canada Eligibility: Practice Ready Assessment (PRA) route to certification. 2017
• Metabolic bone disease adult and paediatric onset. Inter-university diploma, University of Lille II Lille 2 , Bordeaux II, Caen, Lyon, Montpellier, Nancy, Paris 7, France. 2009
• Paediatric Rheumatology. Inter-university diploma, Faculty of Medicine René Descartes Paris V, Necker-Enfants Malades, Paris, France. 2006
• Paediatric oncology. University degree, Gustave Roussy Institute, paediatric oncology,University of Paris 11, Faculty of Medicine Paris Sud, France. 2001
• Specialization in Paediatrics. Catholic University of Louvain (UCL), Belgium. 1999
• Doctorat of medicine, surgery and childbirth (MD), Catholic University of Louvain (UCL ) (Belgium) 1994

• Clinical research in rheumatology and immunology

Career Summary

• Since 2017, Doctor Jean Jacques De Bruycker has been a pediatric rheumatologist and immunologist at the Sainte-Justine university hospital center.
• After 13 years of hospital and subspecialized pediatric practice in oncology, immunology and rheumatology in Belgium, he completed a two-year fellowship in immunology and rheumatology at CHU Sainte-Justine. He then joined the University of Alberta in Edmonton as a pediatric immunologist, finally returning to Montreal.

Presentations

• Suresh S, Vaudry W, Rojas-Vasquez M, Desai S, Murguia-Favela L,  Alobaidi R,  Lewis V, De Bruycker JJ. Rescue Therapy with Granulocyte Transfusions (GT) as a Bridge to Hematopoietic Stem Cell Transplant (HSCT) in a Chronic Granulomatous Disease (CGD) Patient with Severe Disseminated Aspergillosis. Clinical Immunology Society. Atlanta, USA. 2019
• De Bruycker JJ; Selleri S; Decaluwe H; St-Cyr C; Bérubé D; Suzuki T; Nakata K; Le Deist F; Fernandez I and Haddad E. A new case of Hereditary Pulmonary Alveolar Proteinosis caused by CSF2RB mutation: importance of functional testing and biological features to evoke the diagnosis.   Clinical Immunology Society. Baltimore, USA. 2014

Publications

• Lefèvre-Utile A, Merlin E, Kraus R, De Bruycker JJ. Editorial: Impact of environment, physical activity, nutrition and mental health in pediatric rheumatology diseases: towards an integrative approach in patient management. Front Nutr. 2023
• Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin MP, De Bruycker JJ, Couture J, Samaan K, Decaluwe H, Kleiber N, El-Jalbout R, Touzot F, Haddad E, Barsalou J. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Front Med (Lausanne). 2023
• Massey V, Nguyen CE, François T, De Bruycker JJ, Bonnefoy A, Lapeyraque AL, Decaluwe H. CNS Inflammation as the First Sign of Complement Factor I Deficiency: A Severe Myelitis Treated With Intense Immunotherapy and Eculizumab. Neurol Neuroimmunol Neuroinflamm. 2024
• April G, De Bruycker JJ, Decaluwe H, Haddad E, Lambert R, Turpin S. Evaluation of physiological Waldeyer's ring, mediastinal blood pool, thymic, bone marrow, splenic and hepatic activity with 18F-FDG PET/CT: exploration of normal range among pediatric patients. Ann Nucl Med. 2022
• Blain S, Kondyli M, De Bruycker JJ, Winikoff R. Two cases of refractory pediatric antiphospholipid syndrome. Pediatr Blood Cancer. 2022
• Beaufils C, Fernandez I, Marchitto L, Morin MP, De Bruycker JJ, Cellot S, Soucy JF, Ovetchkine P, Oligny L, Haddad E, Touzot F. Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1/2 inhibition. J Allergy Clin Immunol Pract. 2021
• Ledoux-Hutchinson L, Li J, Morin MP, De Bruycker JJ, Tapiero B, Major P. Recurrent Migrating Focal Myositis: A Pediatric Case Report. Can J Neurol Sci. 2022
• Marois L, Touzot F, Haddad E, Fernandez I, Morin MP, De Bruycker JJ, Duval M, Cellot S, Teira P, Bittencourt H, Decaluwe H. Successful management of familial hemophagocytic lymphohistiocytosis by the JAK 1/2 inhibitor ruxolitinib. Pediatr Blood Cancer. 2021
• Coulombe J, Belzile E, Duhamel A, Rault P, Buteau C, De Bruycker JJ, Bussières JF. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept. J Cutan Med Surg. 2019
• Lanternier F, Mahdaviani SA, Barbati E, Chaussade H, Koumar Y, Levy R, Denis B, Brunel AS, Martin S, Loop M, Peeters J, de Selys A, Vanclaire J, Vermylen C, Nassogne MC, Chatzis O, Liu L, Migaud M, Pedergnana V, Desoubeaux G, Jouvion G, Chretien F, Darazam IA, Schäffer AA, Netea MG, De Bruycker JJ, Bernard L, Reynes J, Amazrine N, Abel L, Van der Linden D, Harrison T, Picard C, Lortholary O, Mansouri D, Casanova JL, Puel A. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J Allergy Clin Immunol. 2015